End-tidal carbon dioxide (ETCO2) directed cardiopulmonary resuscitation (CPR)
End-tidal carbon dioxide (ETCO2) directed cardiopulmonary resuscitation (CPR)
批准号:
8736449
负责人:
DONALD H SHAFFNER
金额:
$24.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-19 至 2016-08-31
关键词:
AffectAgeApneaAsphyxiaBasic Life SupportBiochemicalBlindedBlood flowBlood gasBrain Hypoxia-IschemiaCaliberCarbon DioxideCardiacCardiac OutputCardiopulmonary ResuscitationCerebrumChestChildhoodClinical ResearchDataDevelopmentEffectivenessElectric CountershockEnsureEnvironmental air flowEpinephrineEtiologyEventExhalationFeedbackHeart ArrestHypercapniaHypercapnic respiratory failureInduced Heart ArrestInjuryLifeMeasurementMethodsModelingMyocardial perfusionNeonatalNeurological outcomePerformancePhysiologicalPhysiologyProductionRecommendationRespiratory AcidosisRespiratory FailureResuscitationSeveritiesSurvival RateTechniquesTestingTimeUse EffectivenessVentricular FibrillationWorkbasehemodynamicsinjuredneonatal resuscitationnovelpre-clinicalpreclinical studypressureprimary outcomepublic health relevancerespiratoryresponsesecondary outcomeskills
中文摘要
描述(由申请人提供):新生儿心脏骤停是一种罕见的高风险事件,需要最佳的反应才能获得最大的生存率和神经系统预后。关键的心肺复苏(CPR)技能,如胸外按压是基于任意的建议(深度为前后直径的1/3),这给掌握带来了困难。开发一种基于生理反应的新型CPR技术,提供实时、持续的心肺复苏术效果反馈,将对新生儿复苏做出重大贡献。即时的、基于生理的反馈使救援人员能够调整按压的速度和深度,以最大限度地提高生理反应,而不受受害者年龄、体型、原因或骤停时间等因素的影响。我们开发了一种新的技术,在临床前“儿科”模型中使用潮末二氧化碳(ETCO2)引导心肺复苏术(心脏诱发的心室颤动病因),产生与最佳标准儿科心肺复苏术相当的存活率和除颤率。我们建议使用临床前“新生儿”模型(通过窒息引起的呼吸诱发病因)来比较使用etco2定向胸外按压与优化标准新生儿基本生命支持(BLS)。在呼吸性骤停中测试etco2引导的心肺复苏术是很重要的,因为在窒息期间不通气的持续心输出量会比在通气前心输出量停止的心源性骤停产生更高的CO2水平。与优化的标准新生儿心肺复苏术相比,初始二氧化碳负担的增加可能会影响ETCO2水平直接胸外按压的有效性。我们还建议研究在先前呼吸衰竭水平升高的情况下,以etco2为导向的心肺复苏的有效性,以确定窒息前呼吸衰竭对两种心肺复苏方法的影响。这项研究将有助于回答有关这种新颖的心肺复苏术在新生儿复苏的典型情况下的有用性的问题。最后,我们将研究窒息时间对有用性的影响
英文摘要
DESCRIPTION (provided by applicant): Neonatal cardiac arrest is an infrequent, high-stakes event that requires optimal response for maximal survival and neurologic outcome. Key cardiopulmonary resuscitation (CPR) skills such as chest compressions are based on arbitrary recommendations (a depth of 1/3 the anteroposterior diameter) that contribute to difficulty in mastery. The development of a novel CPR technique based on a physiologic response that provides real-time, continuous feedback about the effectiveness of CPR efforts would be a major contribution to neonatal resuscitation. Immediate, physiology-based, feedback allows the rescuer to adjust the rate and depth of compressions to maximize the physiologic response despite factors such as the victim's age or size or the cause or duration of arrest. We have developed a novel technique using end-tidal carbon dioxide (ETCO2)- directed CPR in a preclinical "pediatric" model (cardiac-induced etiology via ventricular fibrillation) of cardiac arest that produces survival and defibrillation rates equivalent to those of optimal standard pediatric CPR. We propose to use a preclinical "neonatal" model (respiratory-induced etiology via asphyxia) of cardiac arrest in piglets to compare the use of ETCO2-directed chest compressions to optimized-standard neonatal basic life support (BLS). It is important to test ETCO2-directed CPR in a respiratory-induced arrest, as the continued cardiac output without ventilation during asphyxia will produce higher CO2 levels than the cardiac-induced arrest in which cardiac output stops before ventilation. This increase in the initial CO2 burden may have an impact on the effectiveness of ETCO2 levels to direct chest compressions in comparison to optimized-standard neonatal CPR. We also propose to study the effectiveness of ETCO2-directed CPR in the setting of increased levels of preceding respiratory failure to determine the effect of respiratory failure prior to asphyxia on both methods of CPR. This study will help to answer questions about the usefulness of this novel CPR technique in arrest scenarios typical for neonatal resuscitation. Finally, we will study the effect of asphyxia duration on the usefulness of
both methods of CPR. Preliminary data appear to indicate that physiology-based CPR may be more useful than standard CPR when injury is severe. All three studies include periods of BLS and advanced life support (ALS) to enable us to determine the impact of epinephrine administration on this novel method of CPR. The demonstration that ETCO2-directed chest compressions are at least as effective as optimal standard neonatal BLS and ALS will serve as the basis for clinical studies of ETCO2-directed chest compressions and further preclinical studies of other physiology-based CPR applications. Showing that this novel physiology- based technique of ETCO2-directed CPR is effective in neonatal arrest scenarios would allow rescuers to focus on maintaining optimal response to compressions rather than on arbitrary parameters that frequently result in inadequate performance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
End-tidal carbon dioxide (ETCO2) directed cardiopulmonary resuscitation (CPR)
-
批准号:8930168
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2014
-
负责人:DONALD H SHAFFNER
-
依托单位:
MAGNESIUM AS A NEUROPROTECTIVE AGENT FOR PEDIATRIC TBI
-
批准号:7200836
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2005
-
负责人:DONALD H SHAFFNER
-
依托单位:
Magnesium as a Neuroprotective Agent for Pediatric TBI
-
批准号:7044742
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2003
-
负责人:DONALD H SHAFFNER
-
依托单位:
Magnesium as a Neuroprotective Agent for Pediatric TBI
-
批准号:6529763
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2001
-
负责人:DONALD H SHAFFNER
-
依托单位:
Magnesium as a Neuroprotective Agent for Pediatric TBI
-
批准号:6400623
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2001
-
负责人:DONALD H SHAFFNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: